Literature DB >> 20567001

Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel.

Alfredo Berruti, Martin Fassnacht, Eric Baudin, Gary Hammer, Harm Haak, Sophie Leboulleux, Britt Skogseid, Bruno Allolio, Massimo Terzolo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20567001     DOI： 10.1200/JCO.2009.27.5958

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  27 in total

Review 1.  Management of adjuvant mitotane therapy following resection of adrenal cancer.

Authors:  M Terzolo; A Ardito; B Zaggia; F Laino; A Germano; S De Francia; F Daffara; A Berruti
Journal:  Endocrine       Date:  2012-06-17       Impact factor: 3.633

2.  Potent antitumor activity of HSP90 inhibitor AUY922 in adrenocortical carcinoma.

Authors:  Junchao Huang; Chengchao Sun; Ting Zhang; Lei Pan; Suqing Wang; Qiqiang He; Dejia Li
Journal:  Tumour Biol       Date:  2014-05-22

3.  Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States.

Authors:  Lauren Gratian; John Pura; Michaela Dinan; Shelby Reed; Randall Scheri; Sanziana Roman; Julie Ann Sosa
Journal:  Ann Surg Oncol       Date:  2014-07-29       Impact factor: 5.344

Review 4.  Management of adrenal cancer: a 2013 update.

Authors:  M Terzolo; F Daffara; A Ardito; B Zaggia; V Basile; L Ferrari; A Berruti
Journal:  J Endocrinol Invest       Date:  2014-03       Impact factor: 4.256

5.  The lack of antitumor effects of o,p'DDA excludes its role as an active metabolite of mitotane for adrenocortical carcinoma treatment.

Authors:  Ségolène Hescot; Angelo Paci; Atmane Seck; Abdelhamid Slama; Say Viengchareun; Séverine Trabado; Sylvie Brailly-Tabard; Abir Al Ghuzlan; Jacques Young; Eric Baudin; Marc Lombès
Journal:  Horm Cancer       Date:  2014-07-16       Impact factor: 3.869

6.  Significance of heparanase-1 and vascular endothelial growth factor in adrenocortical carcinoma angiogenesis: potential for therapy.

Authors:  Yun-Ze Xu; Yu Zhu; Zhou-Jun Shen; Jia-Yan Sheng; Hong-Chao He; Gui Ma; Yi-Cheng Qi; Ju-Ping Zhao; Yu-Xuan Wu; Wen-Bin Rui; Qing Wei; Wen-Long Zhou; Xin Xie; Guang Ning
Journal:  Endocrine       Date:  2011-06-25       Impact factor: 3.633

7.  Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy.

Authors:  Brian K Bednarski; Mouhammed Amir Habra; Alexandria Phan; Denai R Milton; Christopher Wood; Nicholas Vauthey; Douglas B Evans; Matthew H Katz; Chaan S Ng; Nancy D Perrier; Jeffrey E Lee; Elizabeth G Grubbs
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

Review 8.  Adrenocortical carcinoma: patterns of care and role of adjuvant radiation therapy-a population-based study and review of the literature.

Authors:  S Atallah; H Al-Assaf; Y Xu; S El-Sayed
Journal:  Curr Oncol       Date:  2017-08-31       Impact factor: 3.677

9.  A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma.

Authors:  Mouhammed Amir Habra; Shamim Ejaz; Lei Feng; Prajnan Das; Ferhat Deniz; Elizabeth G Grubbs; Alexandria Phan; Steven G Waguespack; Montserrat Ayala-Ramirez; Camilo Jimenez; Nancy D Perrier; Jeffrey E Lee; Rena Vassilopoulou-Sellin
Journal:  J Clin Endocrinol Metab       Date:  2012-11-12       Impact factor: 5.958

10.  Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group.

Authors:  Lauren M Postlewait; Cecilia G Ethun; Thuy B Tran; Jason D Prescott; Timothy M Pawlik; Tracy S Wang; Jason Glenn; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Kara Keplinger; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; Charles A Staley; George A Poultsides; Shishir K Maithel
Journal:  J Am Coll Surg       Date:  2015-12-21       Impact factor: 6.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.